At the same time, such cellular environment of ongoing chronic DNA damage signalling provides a selection pressure that favours outgrowth of tumour cells capable of bypassing this DDR barrier, such as cancer cells with mutant p53, ATM, Chk2, or aberrant DNA repair pathways, among other adaptive alterations. The gene discussed is TP53; the disease is neoplasm.